Advanced Biomed Inc [NASDAQ: ADVB] loss -11.08% on the last trading session, reaching $0.39 price per share at the time.
Advanced Biomed Inc represents 21.64 million in outstanding shares, while the company has a total market value of $8.35 million with the latest information. ADVB stock price has been found in the range of $0.3708 to $0.6999.
If compared to the average trading volume of 194.18K shares, ADVB reached a trading volume of 26123896 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Advanced Biomed Inc [ADVB]:
The Price to Book ratio for the last quarter was 67.11, with the Price to Cash per share for the same quarter was set at 0.01.
Trading performance analysis for ADVB stock
Advanced Biomed Inc [ADVB] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -28.54.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ADVB stock in for the last two-week period is set at 23.75, with the RSI for the last a single of trading hit 0.1047, and the three-weeks RSI is set at 0.1085 for Advanced Biomed Inc [ADVB]. The present Moving Average for the last 50 days of trading for this stock 0.7647, while it was recorded at 0.4435 for the last single week of trading.
Advanced Biomed Inc (ADVB) Capital Structure & Debt Analysis
Advanced Biomed Inc (ADVB) Efficiency & Liquidity Metrics
Based on Advanced Biomed Inc’s (ADVB) latest financial statements, the Debt-to-Equity Ratio is 0.08%, indicating its reliance on debt financing relative to shareholder equity.
Advanced Biomed Inc (ADVB) Efficiency & Liquidity Metrics
An analysis of Institutional ownership at Advanced Biomed Inc [ADVB]
There are presently around $0.05%, or 0.23% of ADVB stock, in the hands of institutional investors.
